Ładuje się......
Higher anti‐tumour efficacy of platinum(IV) complex LA‐12 is associated with its ability to bypass M‐phase entry block induced in oxaliplatin‐treated human colon cancer cells
OBJECTIVES: Therapeutic potential of conventionally used platinum‐based drugs in treatment of colorectal tumours has been limited due to high incidence of tumour resistance to them and to their severe side effects. This evokes a search for more suitable anti‐cancer drugs. We have compared ability of...
Zapisane w:
| Wydane w: | Cell Prolif |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley and Sons Inc.
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6496914/ https://ncbi.nlm.nih.gov/pubmed/24118195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12061 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|